1. Home
  2. AXDX vs FLGC Comparison

AXDX vs FLGC Comparison

Compare AXDX & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXDX
  • FLGC
  • Stock Information
  • Founded
  • AXDX 1982
  • FLGC 2019
  • Country
  • AXDX United States
  • FLGC United States
  • Employees
  • AXDX N/A
  • FLGC 76
  • Industry
  • AXDX Biotechnology: Laboratory Analytical Instruments
  • FLGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXDX Industrials
  • FLGC Health Care
  • Exchange
  • AXDX Nasdaq
  • FLGC Nasdaq
  • Market Cap
  • AXDX 13.7M
  • FLGC 11.7M
  • IPO Year
  • AXDX 1996
  • FLGC 2021
  • Fundamental
  • Price
  • AXDX $0.03
  • FLGC $0.67
  • Analyst Decision
  • AXDX
  • FLGC Strong Buy
  • Analyst Count
  • AXDX 0
  • FLGC 3
  • Target Price
  • AXDX N/A
  • FLGC $5.00
  • AVG Volume (30 Days)
  • AXDX 2.5M
  • FLGC 286.8K
  • Earning Date
  • AXDX 05-20-2025
  • FLGC 05-13-2025
  • Dividend Yield
  • AXDX N/A
  • FLGC N/A
  • EPS Growth
  • AXDX N/A
  • FLGC N/A
  • EPS
  • AXDX N/A
  • FLGC N/A
  • Revenue
  • AXDX $11,698,000.00
  • FLGC $53,260,000.00
  • Revenue This Year
  • AXDX $7.25
  • FLGC $2.33
  • Revenue Next Year
  • AXDX N/A
  • FLGC N/A
  • P/E Ratio
  • AXDX N/A
  • FLGC N/A
  • Revenue Growth
  • AXDX N/A
  • FLGC N/A
  • 52 Week Low
  • AXDX $0.12
  • FLGC $0.42
  • 52 Week High
  • AXDX $2.09
  • FLGC $2.11
  • Technical
  • Relative Strength Index (RSI)
  • AXDX 13.15
  • FLGC 61.10
  • Support Level
  • AXDX $0.12
  • FLGC $0.68
  • Resistance Level
  • AXDX $0.56
  • FLGC $0.75
  • Average True Range (ATR)
  • AXDX 0.05
  • FLGC 0.07
  • MACD
  • AXDX -0.04
  • FLGC 0.02
  • Stochastic Oscillator
  • AXDX 0.00
  • FLGC 82.02

About AXDX Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.

Share on Social Networks: